$362.95 -0.29 (-0.08%) Regeneron Pharmaceuticals Inc - NASDAQ

Jan. 18, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 362.95
Trade Time: Jan 18 04:00 PM Eastern Daylight Time
Change: -0.29 (-0.08%)
Prev Close: 363.24
Open: 363.70
Bid: 362.88
Ask: 362.95
  1. Regeneron, Sanofi Claim Amgen's LDL-Buster Patent Too Broad

    Investors Business Daily | Jan. 17, 2017 | 15:52PM EST
  2. Odds Are Against Regeneron, Sanofi In Amgen Patent Battle: Leerink

    Investors Business Daily | Jan. 13, 2017 | 13:49PM EST
  3. Nasdaq, S&P 500 Hit All-Time Highs; FANG Stocks Show Some Bite

    Investors Business Daily | Jan. 6, 2017 | 15:08PM EST
  4. Could Sanofi Acquire BioMarin In Wake Of Amgen LDL Brouhaha?

    Investors Business Daily | Jan. 6, 2017 | 14:56PM EST
  5. Regeneron, Sanofi Hammered After Judge Bans Amgen-Rivaling LDL-Buster

    Investors Business Daily | Jan. 6, 2017 | 12:45PM EST
  6. Disney's 'Tide Is Turning' But GoPro, McDonald's Served Downgrades

    Investors Business Daily | Jan. 6, 2017 | 09:27AM EST
  7. Stock Futures Ease, Dollar Climbs; Early Risers: Amgen, Ionis, Verizon

    Investors Business Daily | Jan. 6, 2017 | 08:05AM EST
  8. Regeneron, Sanofi LDL-Buster At Risk After Judge Upholds Amgen Patents

    Investors Business Daily | Jan. 4, 2017 | 11:26AM EST
  9. Intro Guide To The Fidelity Select Biotechnology Fund (FBIOX)

    TalkMarkets | Dec. 21, 2016 | 05:54AM EST
  10. Regeneron Likely To Jump On Amgen LDL-Buster, But Expectations Too High

    Investors Business Daily | Dec. 20, 2016 | 15:28PM EST
  11. Morning Call For Tuesday, Dec. 20

    TalkMarkets | Dec. 20, 2016 | 08:54AM EST
  12. Regeneron Could Add $604 Million To 2018 Top Line On Eczema: RBC

    Investors Business Daily | Dec. 13, 2016 | 16:17PM EST
  13. The Basics: Why Industry Loves Company, And Leading Stocks Travel In Groups

    Investors Business Daily | Dec. 13, 2016 | 14:34PM EST
  14. Biotechs Mixed Hurt By Alexion And Ophthotech

    TalkMarkets | Dec. 12, 2016 | 23:03PM EST
  15. Regeneron Spikes On Blurry-Eye Win Vs. Failed Ophthotech Drug

    Investors Business Daily | Dec. 12, 2016 | 13:34PM EST
Trading Center